scholarly journals Ultraviolet light exposure, skin cancer risk and vitamin D production

2015 ◽  
Vol 10 (4) ◽  
pp. 2259-2264 ◽  
Author(s):  
MIGUEL RIVAS ◽  
ELISA ROJAS ◽  
MARÍA C. ARAYA ◽  
GLORIA M. CALAF
2017 ◽  
Vol 99 ◽  
pp. 326-331 ◽  
Author(s):  
Dawn M. Holman ◽  
Zahava Berkowitz ◽  
Gery P. Guy ◽  
Natasha Buchanan Lunsford ◽  
Elliot J. Coups

2013 ◽  
Vol 133 (3) ◽  
pp. 637-641 ◽  
Author(s):  
Jolieke C. van der Pols ◽  
Anne Russell ◽  
Ulrike Bauer ◽  
Rachel E. Neale ◽  
Michael G. Kimlin ◽  
...  

2014 ◽  
Vol 50 (15) ◽  
pp. 2649-2658 ◽  
Author(s):  
Saverio Caini ◽  
Mathieu Boniol ◽  
Giulio Tosti ◽  
Serena Magi ◽  
Matelda Medri ◽  
...  

2014 ◽  
Vol 306 (6) ◽  
pp. 545-553 ◽  
Author(s):  
Xian-Zhi Zhao ◽  
Bao-Hong Yang ◽  
Guo-Hua Yu ◽  
Shu-Zhen Liu ◽  
Zhi-Yong Yuan

Cancers ◽  
2021 ◽  
Vol 13 (10) ◽  
pp. 2344
Author(s):  
Elisabeth A. George ◽  
Navya Baranwal ◽  
Jae H. Kang ◽  
Abrar A. Qureshi ◽  
Aaron M. Drucker ◽  
...  

(1) The incidence of skin cancer is increasing in the United States (US) despite scientific advances in our understanding of skin cancer risk factors and treatments. In vitro and in vivo studies have provided evidence that suggests that certain photosensitizing medications (PSMs) increase skin cancer risk. This review summarizes current epidemiological evidence on the association between common PSMs and skin cancer. (2) A comprehensive literature search was conducted to identify meta-analyses, observational studies and clinical trials that report on skin cancer events in PSM users. The associated risks of keratinocyte carcinoma (squamous cell carcinoma and basal cell carcinoma) and melanoma are summarized, for each PSM. (3) There are extensive reports on antihypertensives and statins relative to other PSMs, with positive and null findings, respectively. Fewer studies have explored amiodarone, metformin, antimicrobials and vemurafenib. No studies report on the individual skin cancer risks in glyburide, naproxen, piroxicam, chlorpromazine, thioridazine and nalidixic acid users. (4) The research gaps in understanding the relationship between PSMs and skin cancer outlined in this review should be prioritized because the US population is aging. Thus the number of patients prescribed PSMs is likely to continue to rise.


Sign in / Sign up

Export Citation Format

Share Document